Evidence map›Paper›PMID 41386981›Full record

ArticleGenome research2026

The oligogenic inheritance test GCOD detects risk genes and their interactions in congenital heart defects.

Maureen Pittman, Kihyun Lee, Franco Felix, Yu Huang, Adrienne Lam, Mauro W Costa, Deepak Srivastava, Katherine S Pollard

Abstract read
In one paragraph

Article in Genome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Current and future diagnostics of congenital heart disease (CHD).Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maureen Pittman *Gladstone Institutes, San Francisco, California 94158, USA.ORCID 0000-0003-3714-991X
Kihyun Lee *Gladstone Institutes, San Francisco, California 94158, USA.ORCID 0000-0002-8754-4128
Franco FelixGladstone Institutes, San Francisco, California 94158, USA.
Yu HuangGladstone Institutes, San Francisco, California 94158, USA.ORCID 0000-0002-9331-728X
Adrienne LamGladstone Institutes, San Francisco, California 94158, USA.
Mauro W CostaGladstone Institutes, San Francisco, California 94158, USA.ORCID 0000-0003-3579-8625
Deepak SrivastavaGladstone Institutes, San Francisco, California 94158, USA; deepak.srivastava@gladstone.ucsf.edu kpollard@gladstone.ucsf.edu.ORCID 0000-0002-3480-5953
Katherine S PollardGladstone Institutes, San Francisco, California 94158, USA; deepak.srivastava@gladstone.ucsf.edu kpollard@gladstone.ucsf.edu.ORCID 0000-0002-9870-6196

Funding

Project 3: Control of cardiac transcription by MEF2 and myocardinP01HL146366 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 2019 to 2023
$13.7M
The Epigenetic Landscape of Heart DevelopmentUM1HL098179 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI BRUNEAU, BENOIT GAETAN, POLLARD, KATHERINE S. · 2015 to 2019
$4.7M
Training in Developmental Cardiovascular BiologyT32HL007544 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SRIVASTAVA, DEEPAK · 1985 to 2021
$4.5M
High-throughput computational modeling to assess the role of 3D genome folding in human congenital anomaliesF31HL156439 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PITTMAN, MAUREEN · 2021 to 2023
$81k
Identification of genetic modifiers of GATA6 in human congenital heart diseasesF32HL158263 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI LEE, KIHYUN · 2021 to 2021
$66k
NHLBI NIH HHS F31 HL156439NHLBI NIH HHS F32 HL158263NHLBI NIH HHS P01 HL146366NHLBI NIH HHS T32 HL007544NHLBI NIH HHS UM1 HL098179
6 · The paper itself

Abstract

Exome sequencing of thousands of families has revealed many risk genes for congenital heart defects (CHDs), yet most cases cannot be explained by a single causal mutation. Even within the same family, individuals carrying a particular mutation in a known risk gene often demonstrate variable phenotypes, suggesting the presence of genetic modifiers. To explore oligogenic causes of CHD without assessing billions of variant combinations, we develop an efficient, simulation-based method to detect gene sets that carry co-occurring damaging variants in probands at a higher rate than expected given parental genotypes. We implement this approach in software called Gene Combinations in Oligogenic Disease (GCOD) and apply it to a cohort of 3377 CHD trios with exome sequencing. This analysis detects 160 gene pairs in which damaging variants are transmitted with higher-than-expected frequency to CHD probands but rarely or never appear in combination in their unaffected parents. Stratifying by specific phenotypes and considering gene combinations of higher orders yields an additional 6026 gene sets. Genes found in oligogenic sets are overrepresented in pathways related to heart development and often co-occur in sets of cell type marker genes from single-cell expression data. Compound heterozygosity of the newly identified digenic pair

Indexed as

Epistasis, GeneticGenetic Predisposition to DiseaseHeart Defects, CongenitalMultifactorial InheritanceSoftwareAnimalsExome SequencingHumansMicePhenotype

Identifiers

PMID41386981
PMCPMC12863180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.